• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Volume 5 - Issue 5 - Sept/Oct 2008

Original Contribution »

Percutaneous Creation of Arteriovenous Shunts

By: John L. Faul, MD and Horst Sievert, MD

Abstract

Reductions in systemic vascular resistance and increased cardiac output are thought to help maintain tissue oxygen delivery during hypoxia. Here we discuss the rationale for creating arteriovenous (AV) shunts in humans and we describe novel techniques for percutaneous creation of AV shunts in patients. Although large AV shunts have been associated with cardiac failure, we believe that the creation of a moderate arteriovenous fistula (AVF) might benefit selected patients with respiratory disease. Here we study the acute effects of an AVF on mixed venous oxygen content and ar

Read the full story »

Original Contribution »

Percutaneous Mechanical Thrombectomy of Acute Lower Extremity Ischemia

By: Paul Papillion, MD, Richard Sprouse, MD, Kevin Allen, BS, Michael Greer, MD, Christopher Lesar, MD, Luke Erdos, MD, Stewart Myers, MD, Daniel Fisher, MD

Abstract

Background. Data are limited regarding the efficacy of percutaneous mechanical thrombectomy (PMT) for the treatment of acute lower extremity (LE) ischemia. The current study was undertaken to evaluate the results following PMT for occluded LE bypass grafts, stents, and thromboembolic events involving native arteries. Methods. During a 3-year period, 43 patients underwent PMT. The patient’s outcome, including the technical success rate, additional procedures, major complications, limb salvage rate, and length of hospital stay were documented for each patient. Ultrasound fol

Read the full story »

Clinical Review »

Why Drug-Eluting Stents May Not Work for Most Patients with Leg Ischemia Caused by Below-Knee Arterial Occlusive Disease

By: Marc Bosiers, MD, Koen Deloose, MD, Jurgen Verbist, MD, Patrick Peeters, MD

Although the use of stents is common in other peripheral vessels, the application of stents remains highly controversial in the infrapopliteal bed (BTK). In general, infrapopliteal stent implantation is reserved for cases with a suboptimal outcome after PTA (i.e., > 50% residual stenosis, flow-limiting dissection). The fear that early thrombosis and late luminal loss due to intimal hyperplasia may lead to suboptimal long-term patency rates explains the reluctance on implanting stents in these small-diameter vessels. In the effort to optimize stent outcomes, coronary drug-eluting stent (DES) te

Read the full story »

Case Report »

Focal Neurologic Symptoms and Diminished Flow to an Upper Extremity Arteriovenous Fistula

By: Prashant Atri, MD, Navyash Gupta, MD

Following Placement of a Thoracic Aortic Endograft: Successful Treatment with Carotid Subclavian Bypass

Introduction

Most traumatic thoracic aortic disruptions occur in the proximal descending thoracic aorta. A significant number of patients with thoracic aortic pathology are found to have disease adjacent to the origin of the great vessels. Endovascular treatment of these injuries often requires either partial or complete intentional coverage of the origin of the left subclavian artery (LSA) in order to obtain an adequate length of the proximal landing zone. The majority

Read the full story »

Case Report and Brief Review »

Successful Angioplasty and Stenting of an Unusual Case of Bilateral Renal Artery Stenosis

By: Tarun Dasari, MD, MPH, Suman Rathbun, MD, MS, Thomas Hennebry, MB, BCh, BAO

Abstract

We report a case of acute renal failure secondary to bilateral renal artery stenosis (RAS) presenting with anuria and well-controlled blood pressure. Renal function improved following percutaneous transluminal angioplasty and stenting (PTA/S). Anuria and well-controlled blood pressure can be an unusual presentation of bilateral RAS, and early detection followed by angioplasty and stenting in this group of patients may lead to an improvement in blood pressure control and preservation of renal functions.

Introduction

Atherosclerotic renal artery stenosis (RAS) is

Read the full story »

Case Report »

Vascular Complications of Osteochondromas: A Report of Two Cases

By: Nuria Torreguitart-Mirada, MD, Jaume Juliá-Montoya, MD, Pascual Lozano-Vilardell, MD

Introduction

Osteochondromas, or exostoses, are the most common form of benign bone tumor, representing about 20–50% of all benign and 10–15% of all bone tumors.1 Patients rarely develop vascular complications. In the English literature, only 106 cases are reported. The development of a pseudoaneurysm, which was first described by Paul in 1953,2 is reported in 58 cases.1,3–7

We report two cases of vascular complications of osteochondromas: a pseudoaneurysm and an arterial occlusion.

Case Report 1

A 22-year-old male with a smoking habit and an HIV infection prese

Read the full story »

Editor's Corner »

Going below the knee: Not without challenges

By: Frank J. Criado Editor-in-Chief Vascular Surgery and Endovascular Intervention; Union Memorial Hospital/ MedStar Health, Baltimore, Maryland frank.criado@medstar.net

By all accounts, leg ischemia caused by below-the-knee (BTK) arterial occlusive arterial lesions is an important and frequent form of atherosclerotic vascular disease. Until the recent past, BTK revascularization was long considered a “sacred domain” of surgical (bypass) treatment — with little if any room left for catheter-based therapy. We know better today.1 The BTK territory, in fact, can be appropriately thought of today as one of the most promising frontiers in the entire endovascular field when the potential for growth and patient benefit are taken into account.

Balloon angiop

Read the full story »

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
    Mon, 05/21/12 - 9:50am
  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
more »

Clinical Events Calendar

  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
  • Peripheral Vascular Surgery Society Annual Spring Meeting
    Thu, 06/07/2012 - Sat, 06/09/2012
    National Harbor, MD, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications